Veradigm Inc (NASDAQ: MDRX) closed the day trading at $6.81 down -10.39% from the previous closing price of $7.60. In other words, the price has decreased by -$0.79 from its previous closing price. On the day, 81854283 shares were traded. MDRX stock price reached its highest trading level at $7.33 during the session, while it also had its lowest trading level at $6.20.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a better understanding of MDRX, let’s look at its different ratios.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barclays on January 03, 2024, initiated with a Equal Weight rating and assigned the stock a target price of $11.
On April 12, 2023, Stephens started tracking the stock assigning a Equal-Weight rating and target price of $13.Stephens initiated its Equal-Weight rating on April 12, 2023, with a $13 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MDRX now has a Market Capitalization of 829.83M and an Enterprise Value of 556.04M. Its current Enterprise Value per Revenue stands at 0.36 whereas that against EBITDA is 1.85.
Stock Price History:
Over the past 52 weeks, MDRX has reached a high of $16.89, while it has fallen to a 52-week low of $6.80. The 50-Day Moving Average of the stock is 9.35, while the 200-Day Moving Average is calculated to be 11.86.
Shares Statistics:
Over the past 3-months, MDRX traded about 2.19M shares per day on average, while over the past 10 days, MDRX traded about 3.31M shares per day. A total of 109.26M shares are outstanding, with a floating share count of 107.73M. Insiders hold about 1.40% of the company’s shares, while institutions hold 104.83% stake in the company. Shares short for MDRX as of Feb 15, 2024 were 8.13M with a Short Ratio of 3.40, compared to 9.43M on Jan 12, 2024.
Earnings Estimates
Current recommendations for the stock of the company come from 7 analysts. On average, analysts expect EPS of $0.3 for the current quarter, with a high estimate of $0.39 and a low estimate of $0.23, while EPS last year was $0.79. The consensus estimate for the next quarter is $0.29, with high estimates of $0.97 and low estimates of $0.09.
Analysts are recommending an EPS of between $0.92 and $0.78 for the fiscal current year, implying an average EPS of $0.84. EPS for the following year is $0.88, with 4 analysts recommending between $1 and $0.81.
Revenue Estimates
6 analysts predict $166.44M in revenue for the current quarter. It ranges from a high estimate of $168.06M to a low estimate of $161.2M. As of the current estimate, Veradigm Inc’s year-ago sales were $391.7M, an estimated decrease of -57.50% from the year-ago figure. For the next quarter, 5 analysts are estimating revenue of $148.44M, an increase of 4.00% over than the figure of -$57.50% in the same quarter last year. There is a high estimate of $154M for the next quarter, whereas the lowest estimate is $143M.
A total of 7 analysts have provided revenue estimates for MDRX’s current fiscal year. The highest revenue estimate was $619.3M, while the lowest revenue estimate was $587.5M, resulting in an average revenue estimate of $610.28M. In the same quarter a year ago, actual revenue was $1.5B, down -59.40% from the average estimate. Based on 7 analysts’ estimates, the company’s revenue will be $628.98M in the next fiscal year. The high estimate is $664.5M and the low estimate is $611.73M. The average revenue growth estimate for next year is up 3.10% from the average revenue estimate for this year.
